We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current QPT market cap is 4.23M. The company's latest EPS is CAD -0.0178 and P/E is -1.12.
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 10k | 0 | 0 | 0 | 0 |
| Operating Income | -13.66M | -1.07M | -790k | -834k | -1.32M |
| Net Income | -13.28M | 190.06M | -85.04M | -7.33M | -3.02M |
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.45M | 175.61M | 91.03M | 84.36M | 24.48M |
| Total Liabilities | 20.95M | 390k | 623k | 1.11M | 1.32M |
| Total Equity | -16.5M | 175.22M | 90.41M | 83.25M | 23.15M |
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -6.38M | -2.52M | -171k | -555k | -343k |
| Investing | 2.78M | 262k | -13k | -13k | N/A |
| Financing | 5.4M | 299k | 250k | 679k | 685k |
| Market Cap | 4.23M |
| Price to Earnings Ratio | -1.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.76 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 169.13M |
| Average Volume (1 week) | 14.95k |
| Average Volume (1 Month) | 17.84k |
| 52 Week Change | -50.00% |
| 52 Week High | 0.055 |
| 52 Week Low | 0.015 |
| Spread (Intraday) | 0.01 (16.67%) |
| Company Name | Quest PharmaTech Inc |
| Address |
4342 - 97 street nw,edmonton edmonton, alberta T6E 5R9 |
| Website | https://www.questpharmatech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
